Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Key Takeaways U.S. health agencies are investigating possible side effects of a chikungunya vaccineOlder adults, especially ...

The FDA and CDC recommended the pause while the government looks into possible side effects. Also: RFK Jr. raises eyebrows after swimming with his grandkids in a contaminated creek; President Donald ...

Federal health officials are advising Americans aged 60 and older to avoid the chikungunya vaccine Ixchiq amid an ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

The ACIP voted to recommend a precaution related to the use of Ixchiq in patients aged 65 years and older ... Chief Medical Officer of Valneva. “We encourage providers to assess the benefit/risk of ...

France’s public health agency, the Haute Autorité de Santé (HAS), has temporarily suspended the use of Valneva’s vaccine Ixchiq in adults ages 65 years and older as authorities investigate ...

French authorities have suspended the use of Ixchiq in people aged 65 years and older pending further investigation. Credit: cagkansayin via Getty Images. French health authorities have suspended the ...

Valneva SE is a specialty vaccine company that ... It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived ...